Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane in elderly advanced breast cancer
NCT02783222Phase 2Completed
- Sponsor
- Fondazione Sandro Pitigliani
- Start
- Jan 2013
- Primary completion
- Sep 2017
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Fondazione Sandro Pitigliani. Started Jan 2013; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02783222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783222.